Cargando…
Circulating immune cell dynamics as outcome predictors for immunotherapy in non-small cell lung cancer
The use of immune checkpoint inhibitors (ICIs) continues to transform the therapeutic landscape of non-small cell lung cancer (NSCLC), with these drugs now being evaluated at every stage of the disease. In contrast to these advances, little progress has been made with respect to reliable predictive...
Autores principales: | Marcos Rubio, Alvaro, Everaert, Celine, Van Damme, Eufra, De Preter, Katleen, Vermaelen, Karim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10401220/ https://www.ncbi.nlm.nih.gov/pubmed/37536935 http://dx.doi.org/10.1136/jitc-2023-007023 |
Ejemplares similares
-
Dendritic Cell-Based Immunotherapy in Lung Cancer
por: Stevens, Dieter, et al.
Publicado: (2021) -
Zipper plot: visualizing transcriptional activity of genomic regions
por: Avila Cobos, Francisco, et al.
Publicado: (2017) -
Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses
por: Vermaelen, Karim
Publicado: (2019) -
Evaluation of a marker independent isolation method for circulating tumor cells in esophageal adenocarcinoma
por: Philippron, Annouck, et al.
Publicado: (2021) -
Potential predictors of immunotherapy in small cell lung cancer
por: Skopelidou, Valeria, et al.
Publicado: (2023)